Related references
Note: Only part of the references are listed.Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Merryn Voysey et al.
LANCET (2021)
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Noa Dagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
Victoria Jane Hall et al.
LANCET (2021)
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
Marie Scully et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
S. A. Madhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures
Cecile Tran Kiem et al.
ECLINICALMEDICINE (2021)
Estimating the burden of SARS-CoV-2 in France
Henrik Salje et al.
SCIENCE (2020)
Age-specific mortality and immunity patterns of SARS-CoV-2
Megan O'Driscoll et al.
NATURE (2020)
New Decade of Vaccines 5 Addressing the vaccine confidence gap
Heidi J. Larson et al.
LANCET (2011)